Baltimore City Reaches Settlement with Purdue Pharma and Teva Pharmaceuticals
Baltimore City’s Historic Settlement
Baltimore Mayor Brandon Scott announced a groundbreaking $80 million settlement with Teva Pharmaceuticals, addressing one of the most pressing issues in public health today – the opioid epidemic.
Settlement Details
This settlement is part of a broader initiative where Baltimore has pursued justice against opioid manufacturers, marking the fourth such agreement reached to date. As part of these settlements, funds are intended to be used for:
- Community education on opioid risks
- Comprehensive addiction recovery services
- Support for affected families
Impact on Baltimore City
Mayor Scott expressed hope that these funds will aid in recovery efforts and contribute significantly to the health of the community, stressing the need for continued action against opioid-related harm.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.